Review article: time to revisit Child‐Pugh score as the basis for predicting drug clearance in hepatic impairment-Reference-Cited by-同舟云学术

Review article: time to revisit Child‐Pugh score as the basis for predicting drug clearance in hepatic impairment

Published:2021-07-04 Issue:4 Volume:54 Page:388-401
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

El‐Khateeb Eman¹²^ORCID,Darwich Adam S.³^ORCID,Achour Brahim¹^ORCID,Athwal Varinder⁴⁵^ORCID,Rostami‐Hodjegan Amin¹⁶^ORCID

Affiliation:

1. Centre for Applied Pharmacokinetic Research University of Manchester Manchester UK

2. Clinical Pharmacy Department Faculty of Pharmacy Tanta University Tanta Egypt

3. Logistics and Informatics in Health Care School of Engineering Sciences in Chemistry, Biotechnology and Health (CBH) KTH Royal Institute of Technology Stockholm Sweden

4. Wellcome Centre for Cell‐Matrix Research Division of Diabetes, Endocrinology and Gastroenterology University of Manchester Manchester UK

5. Research and Innovation Division Central Manchester University Hospitals NHS Foundation Trust Manchester UK

6. Certara UK Ltd. (Simcyp Division) Sheffield UK

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.16489

Reference106 articles.

1. Pitfalls in assessing renal function in patients with cirrhosis--potential inequity for access to treatment of hepatorenal failure and liver transplantation

2. Dose Adjustment in Patients with Liver Disease

3. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017;Sepanlou SG;Lancet,2020

4. A proposal for scientific framework enabling specific population drug dosing recommendations

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Simultaneously Predicting the Pharmacokinetics of CES1-Metabolized Drugs and Their Metabolites Using Physiologically Based Pharmacokinetic Model in Cirrhosis Subjects;Pharmaceutics;2024-02-05

2. Effect of changes in metabolic enzymes and transporters on drug metabolism in the context of liver disease: Impact on pharmacokinetics and drug–drug interactions;British Journal of Clinical Pharmacology;2024-01-25

3. Impact of sarcopenia on postoperative outcomes after hepatectomy in older patients with intrahepatic cholangiocarcinoma: A multicentre cohort study;Liver International;2023-10-07

4. Interpretations of the Role of Plasma Albumin in Prognostic Indices: A Literature Review;Journal of Clinical Medicine;2023-09-22

5. Incorporation and Performance Verification of Hepatic Portal Blood Flow Shunting in Minimal and Full PBPK Models of Liver Cirrhosis;Clinical Pharmacology & Therapeutics;2023-09-09